Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Blood. 2011 Sep 8;118(10):2723-32. doi: 10.1182/blood-2010-09-309989. Epub 2011 Jul 26.
Common myeloid progenitors (CMPs) were first identified as progenitors that were restricted to myeloid and erythroid lineages. However, it was recently demonstrated that expression of both lymphoid- and myeloid-related genes could be detected in myeloid progenitors. Furthermore, these progenitors were able to give rise to T and B lymphocytes, in addition to myeloid cells. Yet, it was not known whether these progenitors were multipotent at the clonogenic level or there existed heterogeneity within these progenitors with different lineage potential. Here we report that previously defined CMPs possess T-lineage potential, and that this is exclusively found in the Flt3(+)CD150(-) subset of CMPs at the clonal level. In contrast, we did not detect B-lineage potential in CMP subsets. Therefore, these Flt3(+)CD150(-) myeloid progenitors were T/myeloid potent. Yet, Flt3(+)CD150(-) myeloid progenitors are not likely to efficiently traffic to the thymus and contribute to thymopoiesis under normal conditions because of the lack of CCR7 and CCR9 expression. Interestingly, both Flt3(+)CD150(-) and Flt3(-)CD150(-) myeloid progenitors are susceptible to Notch1-mediated T-cell acute lymphoblastic leukemia (T-ALL). Hence, gain-of-function Notch1 mutations occurring in developing myeloid progenitors, in addition to known T-lineage progenitors, could lead to T-ALL oncogenesis.
常见髓系祖细胞 (CMP) 最初被鉴定为仅局限于髓系和红细胞系的祖细胞。然而,最近的研究表明,在髓系祖细胞中可以检测到淋巴样和髓系相关基因的表达。此外,这些祖细胞除了能够产生髓系细胞外,还能够产生 T 和 B 淋巴细胞。然而,尚不清楚这些祖细胞在克隆水平上是否具有多能性,或者这些祖细胞中是否存在具有不同谱系潜能的异质性。在这里,我们报告先前定义的 CMP 具有 T 细胞系潜能,并且这种潜能仅在克隆水平上 Flt3(+)CD150(-) 的 CMP 亚群中发现。相比之下,我们在 CMP 亚群中未检测到 B 细胞系潜能。因此,这些 Flt3(+)CD150(-) 髓系祖细胞具有 T/髓系潜能。然而,由于缺乏 CCR7 和 CCR9 的表达,Flt3(+)CD150(-) 髓系祖细胞不太可能在正常情况下有效地迁移到胸腺并有助于胸腺发生。有趣的是,Flt3(+)CD150(-) 和 Flt3(-)CD150(-) 髓系祖细胞都容易受到 Notch1 介导的 T 细胞急性淋巴细胞白血病 (T-ALL) 的影响。因此,在发育中的髓系祖细胞中发生功能获得性 Notch1 突变,除了已知的 T 系祖细胞外,可能导致 T-ALL 肿瘤发生。